Filing Details
- Accession Number:
- 0001127602-25-002645
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-31 20:42:16
- Reporting Period:
- 2025-01-30
- Accepted Time:
- 2025-01-31 20:42:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1730048 | C. Craig Hopkinson | 900 Winter St. Waltham MA 02451 | Evp R&D, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2025-01-30 | 29,156 | $20.03 | 76,732 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2025-01-30 | 26,589 | $19.34 | 103,321 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2025-01-30 | 23,542 | $24.59 | 126,863 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2025-01-30 | 18,345 | $26.82 | 145,208 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-01-30 | 100,918 | $32.05 | 44,290 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2025-01-30 | 29,156 | $0.00 | 29,156 | $20.03 |
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2025-01-30 | 26,589 | $0.00 | 26,589 | $19.34 |
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2025-01-30 | 23,542 | $0.00 | 23,542 | $24.59 |
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2025-01-30 | 18,345 | $0.00 | 18,345 | $26.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 87,566 | 2030-02-20 | No | 4 | M | Direct | |
| 161,734 | 2031-02-22 | No | 4 | M | Direct | |
| 106,758 | 2032-02-18 | No | 4 | M | Direct | |
| 92,271 | 2033-02-23 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.17. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
- These options are fully vested in accordance with their terms.
- Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022.
- Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.
- Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024.
Billionaire Hedge Funds
